A guanine nucleotide regulatory protein may be involved in vasopressin-receptor-mediated polyphosphoinositide breakdown in rat liver. Therefore we examined the effects of the non-hydrolysable guanine 
INTRODUCTION
There is increasing evidence to suggest that a novel guanine nucleotide binding protein is involved in the transduction of hormone-mediated responses involving polyphosphoinositide turnover (see reviews by Joseph, 1985; . The first suggestions for this came from radioligand-binding studies, which showed that guanine nucleotides decreased agonist, but not antagonist, affinities in several tissues and receptor systems involving the phosphoinositide breakdown pathway (for examples see Cantau et al., 1980; Goodhardt et al., 1982; Evans et al., 1985) . One of these, the hepatic vasopressin receptor, has been extensively characterized both biochemically (Hems et al., 1976; Michell et al., 1979; Tolbert et al., 1980; Lynch et al., 1985) and pharmacologically (Michell et al., 1979; Cantau et al., 1980) . In contrast with the kidney V2 receptor, the liver V1 receptor is not coupled to adenylate cyclase, but mediates its glycogenolytic effects via a cyclic AMP-independent mechanism involving the elevation of intracellular Ca2+ concentration secondary to the breakdown of phosphoinositides (Michell et al., 1981) .
The increase in cytosolic Ca2+ as a result of hormone action is believed to be regulated by a product of inositol lipid hydrolysis, myo-inositol 1,4,5-trisphosphate, which is formed as a result of phospholipase C action on membrane-bound phosphatidylinositol 4,5-bisphosphate (Berridge, 1984; Williamson et al., 1985; Fain, 1986) . However, the events occurring between receptor occupation by agonist and phospholipase C activation are at present unclear. By analogy to the well-characterized adenylate cyclase system, it is possible that a guanine nucleotide binding protein may act as a coupling protein between receptor and catalytic component. In order to investigate this possibility, we examined the effects of p[NH]ppG on membrane-bound and detergentsolubilized hepatic vasopressin receptors and on the apparent molecular size of these receptors as measured by gel filtration. Membranes were thawed and incubated in a final volume of 250,1 in assay buffer (50 mM-Tris/HCl, pH 7.4, and 5 mM-MgCl2) containing bacitracin and bovine serum albumin (each 1 mg/ml) and the indicated concentrations of [3H]AVP. To determine non-specific binding, separate incubations were performed in the presence of SuM unlabelled vasopressin. After incubation for 20 min at 30°C (the time necessary for equilibration of binding), the incubations were terminated by the addition of 3.5 ml of ice-cold assay buffer, followed by vacuum filtration over Whatman GF/B glass-fibre filters. These were then washed with 3 x 5 ml of assay buffer, and radioactivity associated with the filters was counted by liquid-scintillation spectroscopy. For dissociation experiments, after equilibration of the membranes with ligand, an excess of unlabelled vasopressin (5/sM final concn.) was added to the tubes to prevent reassociation of label, and incubations were continued for the indicated times.
MATERIALS AND METHODS
For experiments involving the prelabelling of receptors before solubilization, membranes (2-3 mg of protein) were incubated as above, except that the final volume was 2 ml. After the incubation period, the tubes were rapidly cooled and all subsequent steps were performed at 0-4 'C. To separate bound from free ligand, the tubes were centrifuged in a Microfuge at 12000 g for 10 min, followed by two further washes in assay buffer.
Solubilization of vasopressin receptors
The pellet containing prelabelled [3H]AVP-receptor complex was resuspended in 0.55 ml of solubilizing buffer, consisting of 100 mM-Hepes (adjusted to pH 7.4 with NaOH), 50 mM-NaCl, 5 mM-MgCl2 and 0.3 o dodecyl ,B-D-maltoside (see Boer et al., 1983) . The membranes were gently mixed for 30 min at 0°C, followed by centrifugation at 110000 g for 1 h at 0 'C. The clear yellow supernatant (approx. 2 mg of protein/ml) was used directly in all subsequent steps. By this procedure, approx. 5000 of the hepatic vasopressin receptors were solubilized. Measurement of soluble hormone-receptor complex
[3H]AVP bound to soluble receptors was separated from free dissociated ligand on Bio-Gel P30 columns (0.5 cm x 9 cm). Radioactivity eluted in the void volume (0.5-1.5 ml) represented binding to macromolecular complexes.
For estimation of molecular size, the solubilized material (0.5 ml) was applied to a 1.6 cm x 50 cm column containing Ultrogel AcA34 which had been preequilibrated with buffer consisting of 50 mM-Tris/HCl, pH 7.4, 50 mM-NaCl, 5 mM-MgCl2 and 0.10% dodecyl ,/-D-maltoside. The flow rate was 10 ml/h, and 1 ml fractions were collected. Radioactivity was counted by liquid-scintillation spectroscopy, and background radioactivity was subtracted from the results. The gel-filtration column was calibrated with soluble marker proteins of known Mr as follows; thyroglobulin (669 000), apoferritin (443000), fl-amylase (200000), alcohol dehydrogenase (150000), bovine serum albumin (66000), carbonic anhydrase (29000) and myoglobin (17000). 
Protein
Protein was measured by the method of Bradford (1976) with bovine y-globulin as standard.
Expression of results
In all cases except where indicated, the results are expressed as specific binding, which is defined as the difference between total and non-specific binding.
RESULTS
Incubation of liver membranes with increasing concentrations of [3H]AVP revealed that binding was saturable and of high affinity (Fig. la) . Scatchard plots (Fig. lb) but was insensitive to the further addition of nucleotide (Table 1) . The molecular size of the control and p[NH]ppGpreincubated hormone-receptor complex was examined by AcA34 gel filtration.
[3H]AVP-prelabelled solubilized receptor was eluted from the column as a single broad peak (Fig. 3a) , which was quite distinct from non-specific binding. In addition to the receptor-bound peak, a second peak was observed near the total volume, corresponding to free [3H]AVP, which was eluted primarily in fractions 107-113. This peak accounted for approx. 90% of total eluted radioactivity, indicating that most of the [3H]AVP dissociated from specific and non-specific sites during the time taken to run the column (approx. 11 h). The molecular size of the soluble [3H]AVP-receptor complex as analysed from the calibration curve in Fig. 4 was 258000 + 7000 Da (n = 3). In marked contrast with controls, the elution profile of soluble vasopressin receptors prepared from membranes that had been preincubated with [3H]AVP and p[NH]ppG closely followed that obtained for non-specific binding, no detectable peak being observed (Fig. 3b) .
DISCUSSION
Several reports have suggested the involvement of a guanine nucleotide binding protein in hormone-mediated polyphosphoinositide metabolism. Vasopressin has been shown to stimulate a low-Km GTPase in hepatocyte membranes . Moreover, guanine nucleotide effects have been clearly demonstrated in permeabilized cells (Gomperts, 1983; Haslam & Davidson, 1984) , cell-free systems Wallace & Fain, 1985; Uhing et al., 1986 ) and receptor-binding assays (Cantau et al., 1980; Goodhardt et al., 1982; Evans et al., 1985) . guanine nucleotide regulatory protein is well characterized (Lefkowitz & Williams, 1977; Limbird et al., 1980 (Limbird & Lefkowitz, 1978; Limbird et al., 1980) and renal vasopressin receptors (Guillon et al., 1984) . However, it must be emphasized that, in contrast with the adenylate cyclase system, little is known about the coupling of receptors to phospholipase C. It is prudent therefore to consider the possibility of additional components in this system besides the HRG complex which may influence the apparent size of the [3H]AVPreceptor complex. Gel filtration of soluble vasopressin receptors indicated a Mr far in excess of the 68000 reported in studies using photoaffinity-labelling techniques (Boer & Fahrenholz, 1985) . No accurate estimate can be made of the actual size of this complex, because unknown amounts of the detergent are bound to the membrane protein (see Tanford & Reynolds, 1976 (Moreno et al., 1983) , human polymorphonuclear leucocytes Verghese et al., 1985) , mast cells (Nakamura & Ui, 1985) and rabbit neutrophils (Shefcyk et al., 1985) . These effects may be atypical, however, since receptor-mediated events associated with phosphoinositide breakdown are insensitive to pertussis toxin in several cell types Martin et al., 1985; Masters et al., 1985; Houslay et al., 1986; Uhing et al., 1986) . Clearly, further clarification of this issue is necessary. Although our results cannot identify the subtype of G protein involved, the evidence presented here suggests that the phosphoinositide-linked G protein is coupled to receptor in a manner similar to Gs and Gi. Further studies are needed to determine the relationship of this regulatory protein with phospholipase C activation.
